Last reviewed · How we verify

NCT05696119: I-PROTECT

Implementing Injury Prevention Training in Youth Handball (I-PROTECT) Using the RE-AIM Evaluation Framework

Completed NA Last updated 14 April 2026
What this trial tests

NA trial testing I-PROTECT in Athletic Injuries in 4,225 participants. Completed in 18 October 2024.

Timeline
31 May 2023
Primary endpoint
31 May 2024
18 October 2024

Quick facts

Lead sponsorLund University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment4,225
Start date31 May 2023
Primary completion31 May 2024
Estimated completion18 October 2024
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Lund University

Who can join

12 and older, any sex, with Athletic Injuries or Health Behavior. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this two-armed cluster-randomized controlled trial is to investigate the implementation of the I-PROTECT using the RE-AIM evaluation framework that addresses five dimensions of effectiveness and implementation of interventions: reach, effectiveness, adoption, implementation, and maintenance.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Implementing injury prevention training in youth handball (I-PROTECT) in Sweden: study protocol for a cluster randomised trial.
    Ageberg E, Donaldson A, Ström A, Lucander K, et al · · 2024 · cited 2× · PMID 40018138 · DOI 10.1136/bmjph-2024-000991

Verify or expand the search:

Other trials of I-PROTECT

Trials testing the same drug.

Other recruiting trials for Athletic Injuries

Currently open trials in the same condition.

Other Lund University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05696119.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing